How many studies have been conducted on Lipopolysaccharide Binding Protein?

BiohacksAI has indexed 300 PubMed studies on Lipopolysaccharide Binding Protein, including 5 randomized controlled trials (RCTs). 52% of studies involve human subjects.

What are the main research areas for Lipopolysaccharide Binding Protein?

The primary research domains for Lipopolysaccharide Binding Protein are 🔬 Inflammation, 🔥 Metabolic, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Lipopolysaccharide Binding Protein

An acute-phase protein that binds to the lipid a moiety of bacterial LIPOPOLYSACCHARIDES, a glycolipid present in the outer membrane of all GRAM-NEGATIVE BACTERIA. The Lipopolysaccharide-Binding Proteins/Lipopolysaccharide complex may be involved in immune response by interacting with the CD14 ANTIGEN

300+ PubMed studies analyzed · 5 RCTs · Evidence Score: 52.6

Research Domains

Lipopolysaccharide Binding Protein has been studied across 20 research domains including 🔬 Inflammation, 🔥 Metabolic, 🔬 Oncology, 🫁 Liver & Detox, 🛡️ Immunity. The primary research focus is 🔬 Inflammation with 27% of studies addressing this area.

Loading evidence profile...

This evidence profile for Lipopolysaccharide Binding Protein is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.